Intellia Therapeutics, Inc. (NTLA) Just Overtook the 50-Day Moving Average

NTLA has rallied 10.9% over the past four weeks, and the company is a Zacks Rank #3 (Hold) at the moment. This combination suggests NTLA could be on the verge of another move higher. Looking at NTLA's earnings estimate revisions, investors will be even more convinced of the bullish uptrend. There have been 8 higher compared to none lower for the current fiscal year, and the consensus estimate has moved up as well. From a technical perspective, Intellia Therapeutics, Inc. (NTLA) is looking like an interestin ...